NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production Feb 10, 2026 04:03PM
NurExone Biologic Recognized as a 2025 TSX Venture 50(TM) Top Performing Stock Mar 10, 2025 09:00AM